Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir-Ritonavir in Adolescents and Young Adults with Human Immunodeficiency Virus Infection
Jennifer J. Kiser, Peter L. Havens(Children's Hospital of Wisconsin), Courtney V. Fletcher(University of Nebraska at Omaha), Larry R. Muenz(Westat (United States)), D.R. Harris(Westat (United States)), Coleen K. Cunningham(Duke Medical Center), Hanna Major‐Wilson, Bill G. Kapogiannis(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Rolando M. Viani(University of California San Diego), Patricia M. Flynn(St. Jude Children's Research Hospital), Nancy X. Liu(Westat (United States)), Craig M. Wilson(University of Alabama at Birmingham)
Cited by 58
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580